Search
Close this search box.

Highlights

Faberco Life Sciences, Inc, in partnership with Serum Institute of India (SII) is making CovovaxTM, the COVID-19 vaccine developed by

INDIAN pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has committed to making

MANILA, Philippines — Indian pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has

The Serum Institute of India has authorized Faberco Life Sciences, Inc. as the company’s representative in the Philippines in the

THE HEALTH department asked President Rodrigo R. Duterte on Tuesday night to issue an order that will fast-track the approval

Serum Institute of India (SII) over the weekend announced that the Philippine government—through vaccine czar Carlito Galvez Jr.—has inked a

– 100% protection against severe disease – Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19

MANILA, Philippines — National Task Force Against COVID-19 chief implementer Carlito Galvez Jr. is set to fly to India today

Faberco Life Sciences, Inc, in partnership with Serum Institute of India (SII) is making CovovaxTM, the COVID-19 vaccine developed by

INDIAN pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has committed to making

MANILA, Philippines — Indian pharmaceutical company Serum Institute of India (SII), said to be the world’s largest vaccine producer, has

The Serum Institute of India has authorized Faberco Life Sciences, Inc. as the company’s representative in the Philippines in the

THE HEALTH department asked President Rodrigo R. Duterte on Tuesday night to issue an order that will fast-track the approval

Serum Institute of India (SII) over the weekend announced that the Philippine government—through vaccine czar Carlito Galvez Jr.—has inked a